CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
In this webinar, Dr. Mark DeWitt, Postdoctoral Fellow at University of California, discuss the use of gene editing techniques for hematopoietic stem and progenitor cells (HSPCs).
Publish Date:
June 26, 2018
Views: 0
Related Multimedia
-
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017 -
New Tools for the Ex Vivo Expansion of Human Hematopoietic Stem and Progenitor Cells
Publish Date: March 09, 2015 -
Targeting Self-Renewal Function in Normal Hematopoietic and Leukemic Stem Cells
Publish Date: February 03, 2017
Explore Our Products
-
StemSpan™ Erythroid Expansion Supplement (100X)
Serum-free culture supplement for expansion of human erythroid cells -
ArciTect™ Human HPRT Positive Control Kit
Positive control for CRISPR-Cas9 genome editing -
Cas9 nuclease for the generation of double-strand breaks in CRISPR-Cas9 genome editing -
Serum-free medium for culture and expansion of hematopoietic cells
